Funding for this research was provided by:
American Heart Association (16POST31160044, 13SDG17290032, 13SDG16940064)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (P01 HL092969, P30 DK017047)
Received: 29 January 2018
Accepted: 3 July 2018
First Online: 31 July 2018
: D.P., A.F., P.W., P.B., Y.Z., J.M., X.Y., N.P. have nothing to disclose. J.W.H. is named as a co-inventor on patents from the US Patent Office on the use of HDL markers to predict the risk of cardiovascular disease. Dr. Heinecke has served as a consultant for Kowa, Merck, Amgen, Bristol Meyer Squibb, GSK, and Pacific Biomarkers. No present conflict of interest for all the authors.